132 related articles for article (PubMed ID: 16075462)
21. Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.
Song Z; Li R; You N; Tao K; Dou K
Mol Biol Rep; 2010 Dec; 37(8):4091-101. PubMed ID: 20300861
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
[TBL] [Abstract][Full Text] [Related]
23. The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.
Lin YW; Yan MD; Shih YL; Hsieh CB
Eur J Cancer; 2009 Jul; 45(11):2041-9. PubMed ID: 19410446
[TBL] [Abstract][Full Text] [Related]
24. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan.
Chou YH; Chung KC; Jeng LB; Chen TC; Liaw YF
Cancer Lett; 1998 Jan; 123(1):1-6. PubMed ID: 9461010
[TBL] [Abstract][Full Text] [Related]
25. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
[TBL] [Abstract][Full Text] [Related]
26. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
[TBL] [Abstract][Full Text] [Related]
27. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
28. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
29. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
Zhao X; Wan D; Jiang H
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.
Kahng YS; Lee YS; Kim BK; Park WS; Lee JY; Kang CS
J Gastroenterol Hepatol; 2003 Apr; 18(4):430-6. PubMed ID: 12653892
[TBL] [Abstract][Full Text] [Related]
31. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
32. Deletion mapping of chromosome 4q in hepatocellular carcinoma.
Piao Z; Park C; Park JH; Kim H
Int J Cancer; 1998 Aug; 79(4):356-60. PubMed ID: 9699526
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
[TBL] [Abstract][Full Text] [Related]
34. Preferentially deleted chromosome region 9p21 in large hepatocellular carcinomas.
Chung MY; Wu JC; Chau GY; Lui WY; Tsay SH; Chiang H
Int J Mol Med; 2000 May; 5(5):521-4. PubMed ID: 10762656
[TBL] [Abstract][Full Text] [Related]
35. Structure and expression of Tg737, a putative tumor suppressor gene, in human hepatocellular carcinomas.
Bonura C; Paterlini-Brechot P; Brechot C
Hepatology; 1999 Sep; 30(3):677-81. PubMed ID: 10462374
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
[TBL] [Abstract][Full Text] [Related]
37. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas.
Herath NI; Kew MC; Walsh MD; Young J; Powell LW; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2002 Mar; 17(3):301-7. PubMed ID: 11982701
[TBL] [Abstract][Full Text] [Related]
39. [Study on loss of heterozygosity and microsatellite instability in hepatocellular carcinoma].
Cong WM; Zhang SH; Xian ZH; Wu WQ; Wu MC
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):71-4. PubMed ID: 15842799
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between microsatellite alterations on chromosome 8 and clinicopathological characteristics in hepatocellular carcinoma].
Zhang SH; Cong WM; Xian ZH; Wu MC
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):429-32. PubMed ID: 15498212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
